Companies
(73)
AAC Clyde Space
ALM Equity
Alzinova
Arion Bank
Arlandastad Group
Ascelia Pharma
Bactiguard
Bergman & Beving
Besqab
BioPorto
Björn Borg
Bokusgruppen
Bonava
BTS Group
Byggmästaren
CAG Group
Calviks
Carasent
CDON
Clavister
Clemondo Group
eEducation Albert
Elanders
Elicera Therapeutics
Eolus
Ependion
EQL Pharma
Faron Pharmaceuticals
FluoGuide
Gentoo Media
GiG Software
HAKI Safety
HANZA
Iconovo
Idun Industrier
InfraCom
Initiator Pharma
Intervacc
ITAB Group
Kebni
Lifecare ASA
Lindex Group
Logistri
Lumi Education Group
Lytix Biopharma
Medivir
Mentice
Micro Systemation
MilDef Group
Net Insight
Nordic LEVEL Group
Orexo
Ortoma
OssDsign
Paxman
Pierce
PowerCell
Pricer
Qualisys
Relais Group
SaltX
Scanfil
Sensys Gatso Group
Sleep Cycle
Solar Foods
Spago Nanomedical
Svedbergs Group
Taaleri
Terranor
Vertiseit
Vivesto
W5 Solutions
Waystream
Sweden
Capital Goods
Latest share price
SEK
20 Nov 2026 17:29 CET
Fair value range
SEK
22 Oct 2026
Market cap
SEK
m
Next report
2 Feb 2027
HAKI Safety
Capital Goods
2026-10-22
Sales of SEK311m (+8% Y/Y, organic -4%) were 7% below our estimate, while adj. EBITA of SEK14m missed our SEK27m forecast by 48%. The margin was 4.5% (8.3% in Q3 2025),...
Post-Results Note
Mathias Carlson
Order delays cloud recovery; FV lowered - Q3 review
Organic weakness slows recovery - Q3 initial take
Growth continues; Combisafe in focus - Q3 preview
HAKI Safety
Capital Goods
2026-10-20
Q3 sales were SEK311m, up 8% Y/Y but 7% below our SEK335m forecast, with organic growth of -4% versus our +9% estimate. Adj. EBITA was SEK14m, down 42% Y/Y and 48% below...
News
Mathias Carlson
Order delays cloud recovery; FV lowered - Q3 review
Organic weakness slows recovery - Q3 initial take
Growth continues; Combisafe in focus - Q3 preview
HAKI Safety
Capital Goods
2026-10-05
We expect Q3 sales of SEK335m (+16% Y/Y), adj. EBITA of SEK27m (+13% Y/Y) and an adj. EBITA margin of 8.1% (8.3% in Q3 2025). In our view, continued organic growth...
Pre-Results Note
Mathias Carlson
Order delays cloud recovery; FV lowered - Q3 review
Organic weakness slows recovery - Q3 initial take
Growth continues; Combisafe in focus - Q3 preview
Price
Fair range high value
Fair range low value
Year
2024
2025
2026e
2027e
2028e
EPS
1.50
1.19
1.67
2.12
2.75
EPS (Adj.)
1.76
1.30
1.63
2.39
3.02
Sales Growth
-11.62%
12.29%
9.68%
8.09%
5.00%
EPS Growth (Adj.)
-17.20%
-26.27%
26.02%
46.10%
26.45%
P/E
12.3
15.5
11.1
8.7
6.7
P/E (Adj.)
10.5
14.3
11.3
7.8
6.1
EV/EBITA
13.9
12.8
10.9
8.4
6.3
EV/EBITDA
6.8
5.8
5.6
4.5
3.7
Learn more
Sector
Capital Goods
Country
Sweden
Tickers
HAKIB@SS, HAKIb.ST
CEO
Sverker Lindberg
CFO
Tomas Hilmarsson
Webpage
www.hakisafety.se
About DNB Carnegie Access
DNB Carnegie Access aim is to connect listed companies with the capital markets. Through top ranked public equity research and broad distribution via written reports, seminars, video, and podcasts, we increase visibility and investor understanding for small- and medium-sized companies, both among institutional and private investors.
Along with corporate finance, market making and certified advisory we provide a complete product offering to our clients.
Private Banking
Tailored wealth management. Your financial future, personalized.
Montrose
A digital investment platform designed for passionate investors.
DNB Carnegie
Leading Nordic investment bank and wealth management.
© Copyright DNB Carnegie Investment Bank AB